AMLX vs FFIV · $561.6M cap vs P/E 32, rev $3.09B
Amylyx Pharmaceuticals Inc (AMLX) versus F5 Networks Inc (FFIV) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
F5 Networks Inc (FFIV) is a software - infrastructure company listed on NASDAQ.
Latest reported AMLX revenue for 2025-12-31 was $0. Net income was -$144.7M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. AMLX currently screens at market cap $561.6M.
Latest reported FFIV revenue for 2025-09-30 was $3.09B. Net income was $692.4M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
AMLX currently screens at market cap $561.6M. FFIV currently screens at market cap $21.71B and trailing P/E 31.6.
Not investment advice. Open the AMLX and FFIV stock pages for the full models.
Not investment advice.